New Studies Examine the Use of Liquid Biopsies and the Possible Causes of Myeloma

Two newly published studies that received funding from the IMF Black Swan Research Initiative® show how myeloma might be diagnosed and monitored in the future, and, perhaps, the genetic factors that might cause the disease. In his blog this week, IMF Chairman Dr. Brian Durie translates the studies’ implications and offers important caveats for patients to keep in mind. 

 

The Secrets to a Long, Healthy Life Remain Elusive: Updates from Around the World

The Tsimane tribe lives in the Amazon lowlands of Bolivia. For some reason, according to a new study published in The Lancet, they do not get heart disease! The study, notes the New York Times, paired anthropologists with cardiologists to investigate.

PET/CT Scanning Comes of Age: New IMWG Guidelines Published

New IMWG guidelines for PET/CT scanning have been published inThe Lancet Oncology. In his blog this week, IMF Chairman Dr. Brian Durie congratulates Dr. Michele Cavo and his team for their report on this extremely accurate imaging technique, used to establish a diagnosis and to monitor throughout the course of the disease. “The new IMWG guidelines provide a comprehensive review of the current role and optimal uses of FDG PET/ CT scanning,” he writes.

US FDA Lifts Partial Clinical Hold on Karyopharm’s Selinexor Clinical Trials

When there is so much that is negative in the news, it is great to be able to report today that myeloma clinical trials with selinexor (KPT-330) can again move forward.

International Myeloma Workshop: the spirit of India and the emerging myeloma community

The 16th International Myeloma Workshop was held in New Delhi, India March 1-4. This gathering of those interested in myeloma from around the world was definitely a global amalgam. The format included multiple short presentations to encompass the full range of scientific and clinical topics.

Pages